Skip to main content
Clinical Trials/NCT01438697
NCT01438697
Completed
Phase 3

An Internet Intervention for Insomnia: Efficacy and Dissemination

University of Virginia1 site in 1 country303 target enrollmentOctober 2011

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Insomnia
Sponsor
University of Virginia
Enrollment
303
Locations
1
Primary Endpoint
Primary sleep symptoms: sleep onset latency (SOL), wake after sleep onset (WASO), insomnia severity (ISI)
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

This study will compare the efficacy of an interactive Internet intervention for adult insomnia (Sleep Healthy Using the Internet; SHUTi) to that of a static educational website to improve sleep, mood related symptoms, perceived health status, and overall quality of life.

Detailed Description

Insomnia is defined by complaints of poor sleep, as well as difficulties initiating and/or maintaining sleep more than 3 nights/week for more than 6 months. Insomnia may contribute to daytime fatigue, impaired performance, confused thinking and judgment, and difficulty with work and personal tasks. Cognitive behavioral therapy (CBT) has been found to have significant short- and long-term benefits for people with insomnia. Access to CBT for many people, however, is limited, due to the high cost of treatment and a limited number of trained professionals. Delivering CBT for insomnia via the Internet could help make it more widely available. This study will compare the effectiveness of an online CBT intervention in improving sleep, mood, and quality of life in people with insomnia to that of a static educational website. Participants in this study will be randomly assigned to receive the online CBT intervention or the static patient education website. The intervention period will last for 9 weeks. During the intervention period, participants assigned to the patient education website will be given content addressing strategies for dealing with insomnia. Those assigned to use the Internet intervention will review interactive, tailored content specific to the user's difficulties. Participants will complete questionnaires and two weeks of daily sleep diaries about their symptoms at four time points - at the beginning of the study, immediately after completing the 9 week program, 6 months later, and 12 months later.

Registry
clinicaltrials.gov
Start Date
October 2011
End Date
October 2014
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Karen Ingersoll

Associate Professor, Department of Psychiatry and NB Sciences

University of Virginia

Eligibility Criteria

Inclusion Criteria

  • Age between 21 and 65 years old.
  • Have sleep-onset insomnia and/or sleep maintenance insomnia (\>30 minutes for at least 3 nights/week).
  • Have insomnia symptoms lasting at least 6 months.
  • Have an average total sleep time ≤ 6.5 hours.
  • Sleep disturbances (or associated daytime fatigue) cause significant distress or impairment in social, occupational, or other areas of functioning.
  • Have regular access to a computer and the Internet.
  • Reside in the United States or are US Citizens living outside the United States

Exclusion Criteria

  • Pregnancy
  • Report of a physical illness which is deemed active, unstable, degenerative, and/or progressive, such as congestive heart failure, dementia, or acute pain.
  • Bipolar disorder as defined by a manic or hypomanic episode or treatment within the past 10 years.
  • Severe depression.
  • Endorse risk of suicide.
  • Endorse alcohol or drug abuse within the past year.
  • Presence of another untreated sleep disorder (e.g., sleep apnea, periodic leg movements).
  • Have irregular sleep schedules, with usual bedtimes earlier than 8:00pm or later than 2:00am or arising times earlier than 4:00am or later than 10:00am.
  • Current psychological treatment for insomnia.
  • Initiating psychological treatment within past 3 months.

Outcomes

Primary Outcomes

Primary sleep symptoms: sleep onset latency (SOL), wake after sleep onset (WASO), insomnia severity (ISI)

Time Frame: Baseline, 9 weeks, 6 months, 1 year

Secondary Outcomes

  • Health symptoms: fatigue, quality of life(Baseline, 9 weeks, 6 months, 1 year)
  • Cost effectiveness: program delivery cost, participant resource utilization and costs, quality adjusted life years (QALYs)(9 weeks, 6 months, 1 year)
  • Intervention Evaluation: perceived utility, perceived impact, intervention adherence, intervention use(9 weeks, 6 months, 1 year)
  • Exploratory Outcome Measures: health care access, coverage and utilization(Baseline, 9 weeks, 6 months, 1 year)
  • Secondary sleep symptoms: sleep efficiency (SE), number of night time awakenings, sleep quality, total sleep time (TST)(Baseline, 9 weeks, 6 months, 1 year)
  • Psychological distress: levels of depression, levels of anxiety, sleep-related cognitions(Baseline, 9 weeks, 6 months, 1 year)

Study Sites (1)

Loading locations...

Similar Trials